Rejoignez-nous aux Careers Days d’AIESEC in Switzerland à l’University of Geneva ! 📅 Date : 29 octobre 🕙 Heure : 10h00 – 11h00 📍 Lieu : Uni Mail, salle M1130 La FONGIT présentera ses missions ainsi que deux start-up qu’elle soutient, Beekee et Planeto, qui témoigneront de leurs innovations dans les domaines de l’apprentissage numérique et de la transition énergétique. 👉 Étudiant·e à l’UNIGE ou simplement curieux·se d’en savoir plus ? Rejoignez-nous !
FONGIT
Gemeinnützige Organisationen
Plan-les-Ouates, Geneva 10.920 Follower:innen
The Innovation Platform
Info
We support entrepreneurs with the expertise, resources and financing they need in transforming innovative ideas into sustainable companies. We are a private, non-profit foundation, benefitting from the support of the State of Geneva. Our mission is to transform innovation into social and economic value in the Geneva region. We currently support over 220 innovative early-stage ventures by providing financing, targeted coaching, fully-equipped offices & labs, administration, legal help & accounting, and a vibrant community.
- Website
-
https://www.fongit.ch
Externer Link zu FONGIT
- Branche
- Gemeinnützige Organisationen
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Plan-les-Ouates, Geneva
- Art
- Nonprofit
- Gegründet
- 1991
- Spezialgebiete
- start-ups, ICT, medtech, engineering, industry 4.0, cleantech, life sciences, internet of things, digital, innovation, entrepreneurship, Pharma, Biotech, diagnostics, digital health, fintech, blockchain, security und deeptech
Orte
-
Primär
Wegbeschreibung
Route de la Galaise 34
Plan-les-Ouates, Geneva 1228, CH
Beschäftigte von FONGIT
Updates
-
🎉 Congratulations to Giovanna Dipasquale, CEO of Herosupport SA, on winning the Female Innovator of the Year Award! 👏 HeroSupport is a medtech startup developing a personalized 3D printing solution that enhances the precision of radiotherapy treatments. This innovation improves the accuracy and comfort of MRI scans, reduces the need for staff training and patient setup time, and increases hospital efficiency while optimizing outcomes for patients. A remarkable achievement that highlights HeroSupport’s work at the forefront of the fight against breast cancer! Read more on Startupticker.ch: https://lnkd.in/ei9wqjzT
What to say? Just thank you for supporting our mission and recognising the wish, the need for better breast cancer care for women (and men) and our work at Herosupport SA. A Big Thank you to Dr. Mania Aspradakis for representing me at the event, as very unfortunately I could not join. A Big Thank you to the team, Cristina Riccadonna, Pauline Guillemin, Johan Uiterwijk, Karine Ambrosetti, Katarina Uiterwijk, Wioletta Kozlowska and Michael Sandhu. A Big Thank you to Swiss Ladies Drive GmbH and JED Campus. I hope to continue exchanging and, who knows, push forward women's need with new form of collaborations. Finally a Big Thank you to all the friends and Herosupport-ers and of course AUDI AG sponsor of the award! #innovation #Fightcancer #VENUSSHELL
-
-
🎙️ Ne manquez pas le dernier épisode d'Alp ICT #TechTalk ! Thibault Clément, CEO et co-fondateur de Popety.io, y partage l’histoire de la start-up et explique comment l’Open Data permet de faire émerger de nouvelles solutions prometteuses dans le secteur immobilier. 💡 Une discussion passionnante sur la stratégie et les enjeux autour de l’Open Data, à ne pas rater ! 🔗 Retrouvez l’épisode complet: https://lnkd.in/eAGpaQfj
🎙️ IA & Open Data : clés de voûte d'une économie plus agile 👀 Ce nouvel épisode #TechTalk nous rappelle à quel point le monde de l’entreprise est en train de changer. Il ne s’agit pas d’un cours magistral sur les tenants et les aboutissants de la révolution numérique, mais bel et bien d’une plongée concrète au cœur de l’entrepreneuriat 4.0, au côté de Thibault Clément, ingénieur de formation, désormais CEO de la start-up Popety.io, une solution de prospection pour les professionnels de l’immobilier en Suisse, basée sur l’#OpenData. 👨🍳 Au programme : https://lnkd.in/dNhsh3JM • Immobilier 4.0 en Suisse romande • Stratégie & enjeux autour de l'Open Data • #IA & #VibeCoding : le futur de l'entrepreneuriat • Entre compétitivité & employabilité : des modèles qui se réinventent 💡 La vision de Thibault ? Bien qu’ingénieur acquis à la cause, Thibault ne fera pas pour autant l’apologie technique de la technologie, car il l’avoue lui-même: c’est la première fois qu’il utilise des outils qu’il ne comprend pas entièrement. Ce constat n’a rien d’une faiblesse, il n’a pas non plus pour objet d’effrayer, c’est la lucidité d’un ingénieur devenu dirigeant, conscient de la rupture que ces technologies imposent. 🧠 Abonnez-vous à la chaine youtube.com/@alp-ict pour ne manquer aucun des prochains RDV #TechTalk & retrouvez également l'intervention de Thibault en Podcast sur votre plateforme préférée : https://lnkd.in/d4pWeZ5u #SwissInnovation #SwissTech #TransformationDigitale
-
FONGIT hat dies direkt geteilt
CHF 40,000 for Eldian Biomed, NanoZymeX, and OOVIE Studios SA. These three projects were selected at Venture Kick's second financial and entrepreneurial support stage. 💰 https://lnkd.in/d5ExKmmx Meet the three successful projects: CEO Gregor Bordon, PhD | Eldian Biomed: Injectable microcushions for damaged joints. 🦵 https://lnkd.in/dVcRs55D Margarita C. Dinamarca & Boris Sevarika | NanoZymeX: Delivering enzyme therapies precisely where they are needed. 💊 https://lnkd.in/dn3KpwzV CAO & Sales Giulio Casagrande, CTO Ignacio Palladino, CEO Riccardo Acciarino, CMO Lorenzo Ramon, and COO Marco Seco | OOVIE Studios SA: Interactive AI movies that change every time you watch them. 🎬 https://lnkd.in/gQqGeQww #VentureKick #SwissStartups
-
-
🚀 𝗧𝗵𝗲 𝗦𝘄𝗶𝘀𝘀 𝗜𝘁𝗮𝗹𝗶𝗮𝗻 𝗦𝘁𝗮𝗿𝘁𝘂𝗽 𝗔𝘄𝗮𝗿𝗱 𝗶𝘀 𝗯𝗮𝗰𝗸 𝗳𝗼𝗿 𝗶𝘁𝘀 𝟮𝗻𝗱 𝗲𝗱𝗶𝘁𝗶𝗼𝗻! Following the success of last year’s event, the #SwissItalianStartupAward, organised by the Camera di Commercio Italiana per la Svizzera under the patronage of the Italian Embassy in Bern and the Consulate General of Italy in Geneva and in collaboration with key ecosystem partners, will once again bring together leading Italian entrepreneurs and investors in Geneva. The event celebrates innovation, entrepreneurship and cross-border cooperation, strengthening the connections between the Swiss and Italian startup communities. ✨Expect an evening of engaging presentations, high-impact networking, and innovative ideas from leading entrepreneurs. Congratulations to the 9 selected startups that will take the stage in the prestigious pitch competition: Cria Technologies, Fideliomed, HEREMOS, Herosupport SA, HYBA , InkVivo Technologies AG, OOVIE Studios SA, SmartCloudFarming, and Valueize. 🗓️ Tuesday, 18 November | 5:00–10:00 pm 📍 Campus Biotech, Geneva 👉 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗯𝘆 𝟭𝟭 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿. 𝗦𝗲𝗮𝘁𝘀 𝗮𝗿𝗲 𝗹𝗶𝗺𝗶𝘁𝗲𝗱: https://lnkd.in/eQFf-YJa Partners: ITA - Italian Trade Agency, pizzatech, Swiss Chamber - Camera di Commercio Svizzera in Italia, Federated Innovation @MIND, FONGIT, Sisterpreneurs & Sisters Founders, ARTI Puglia – Agenzia Regionale per la Tecnologia, il Trasferimento tecnologico e l’Innovazione, Gyrus Capital Sponsors: Allianz Suisse, Alpian Bank, confinis, Forvis Mazars, Lenz & Staehelin, STMicroelectronics, Swiss Institute of Tech and Enterpreneurship, McCann Health, HSBC Private Bank
-
-
🔬 Curious about the soon-to-be-launched Superlab Suisse facilities at Campus Biotech? ☕ 🥐 Get an exclusive look at what’s next for Geneva’s life sciences ecosystem at our Life Sciences Café+Croissant. Hear insights directly from Superlab Suisse's CEO, ZHANG Xi, and connect with the people shaping the region’s life sciences landscape. Discover new opportunities and grow your network in a friendly and inspiring setting. 📅 30 October I 9:30 - 10:30 am 📍Campus Biotech 🔗 Register to secure your spot: https://lnkd.in/guq7dJHX
-
-
🏆 Félicitations aux start-up récompensées lors de la 19ᵉ édition de la Journée de l’innovation des HUG - Hopitaux Universitaires de Genève ! Trois projets soutenus par la FONGIT se sont distingués : 🔸 𝐅𝐥𝐨𝐰 𝐓𝐰𝐢𝐧 – 𝑃𝑟𝑖𝑥 𝑅𝑜𝑐𝑘𝑒𝑡 (Jeremy Hofmeister) 🔸 POSICS DeepView Camera – 𝑃𝑟𝑖𝑥 𝐶𝑜𝑢𝑝 𝑑𝑒 𝑝𝑜𝑢𝑐𝑒 𝑑𝑢 𝑗𝑢𝑟𝑦 (Domenico della Volpe) 🔸 LaxiPed – 𝑃𝑟𝑖𝑥 𝑑𝑢 𝑚𝑒𝑖𝑙𝑙𝑒𝑢𝑟 𝑝𝑜𝑠𝑡𝑒𝑟 (Quentin Praz, Spyridon Schoinas) 🔗 Découvrez le communiqué de presse : https://lnkd.in/eU5dd5v8 Centre de l'innovation des HUG
-
-
Proton's Lumo has been recognized by TIME Magazine as one of the Best Inventions of 2025 in the Privacy & Security category. Built with privacy at its core, Lumo is a zero-access encrypted AI chatbot that doesn’t track or record your conversations, and all data is stored locally on your device. ➡️ Try Lumo: https://lnkd.in/e88fnWBF 📰 https://lnkd.in/e4WVSuCm
-
-
📰 Découvrez l’article de notre directeur, Antonio Gambardella, récemment publié dans Bilan Magazine et intitulé « IA : la Suisse n’a plus le luxe d’attendre ». Un appel clair à préserver notre position de digital trust nation et à soutenir l’innovation plutôt que de la freiner. 🔗 Lire l'article en entier ici: https://lnkd.in/eDmg8Cu3
-
-
🧬 “𝗘𝗻𝘁𝗿𝗲𝗽𝗿𝗲𝗻𝗲𝘂𝗿𝘀𝗵𝗶𝗽 𝗶𝘀 𝗻𝗼𝘁 𝗮𝗯𝗼𝘂𝘁 𝗵𝗮𝘃𝗶𝗻𝗴 𝗮𝗹𝗹 𝘁𝗵𝗲 𝗮𝗻𝘀𝘄𝗲𝗿𝘀. 𝗜𝘁’𝘀 𝗮𝗯𝗼𝘂𝘁 𝗱𝗮𝗿𝗶𝗻𝗴 𝘁𝗼 𝘁𝗮𝗸𝗲 𝘁𝗵𝗲 𝗳𝗶𝗿𝘀𝘁 𝘀𝘁𝗲𝗽, 𝗹𝗲𝗮𝗿𝗻𝗶𝗻𝗴 𝗿𝗲𝗹𝗲𝗻𝘁𝗹𝗲𝘀𝘀𝗹𝘆, 𝗮𝗻𝗱 𝗯𝗿𝗶𝗻𝗴𝗶𝗻𝗴 𝗼𝘁𝗵𝗲𝗿𝘀 𝗮𝗹𝗼𝗻𝗴 𝘁𝗼 𝗺𝗮𝗸𝗲 𝘁𝗵𝗲 𝗶𝗺𝗽𝗼𝘀𝘀𝗶𝗯𝗹𝗲 𝗿𝗲𝗮𝗹”. Discover the journey of co-founders Jan Nelis and Amir Taheri-Ghahfarokhi, and how their ETH spinoff, Immitra Bio GmbH, is advancing genetic therapies for rare diseases. In February, Immitra Bio was awarded a FIF Seed Loan to support its mission to translate scientific research into treatments for rare diseases and strengthen collaborations with Geneva’s world-class research institutes. ⬇️ Read the full story to see how their team is pushing the boundaries of biotech innovation.